Literature DB >> 17053366

Atazanavir urinary stones in an HIV-infected patient.

Jérôme Pacanowski, Jean-Marie Poirier, Isabelle Petit, Jean-Luc Meynard, Pierre-Marie Girard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053366     DOI: 10.1097/01.aids.0000247571.88256.90

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

1.  Recurrent nephrolithiasis associated with atazanavir use.

Authors:  Lily C Wang; E Charles Osterberg; Scott G David; James S Rosoff
Journal:  BMJ Case Rep       Date:  2014-01-08

2.  Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.

Authors:  Chad J Achenbach; Kristin M Darin; Robert L Murphy; Christine Katlama
Journal:  Future Virol       Date:  2011-02       Impact factor: 1.831

3.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

Review 4.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

5.  Renal stone composed of ritonavir.

Authors:  Anna M Zhao; Nancy R Angoff
Journal:  BMJ Case Rep       Date:  2019-07-01

Review 6.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  Atazanavir: its role in HIV treatment.

Authors:  Robin Wood
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

8.  Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient.

Authors:  Yoji Moriyama; Yuzuru Minamidate; Mitsuru Yasuda; Hidetoshi Ehara; Mina Kikuchi; Tomohiro Tsuchiya; Takashi Deguchi; Hisashi Tsurumi
Journal:  Urol Res       Date:  2008-07-17

Review 9.  Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment.

Authors:  Sarah M McCabe; Qing Ma; Judianne C Slish; Linda M Catanzaro; Neha Sheth; Robert DiCenzo; Gene D Morse
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.

Authors:  Matthieu Lafaurie; Barbara De Sousa; Diane Ponscarme; Nathanael Lapidus; Michel Daudon; Laurence Weiss; Christophe Rioux; Erwan Fourn; Christine Katlama; Jean-Michel Molina
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.